Stem Cell Clinical Trials: Staying on the Critical Path Workshop | Intro by Ellen Feigal, CIRM

 

The mission of California's Stem Cell Agency (CIRM) is to advance stem cell based science toward clinical trials to create opportunities to bring new effective and curative therapies to patients. At the March 6-8, 2013 CIRM Grantee Meeting, Senior VP of R&D Ellen Feigal held a workshop for CIRM grantees to help them increase their understanding of the pathway to develop a stem cell based product for patients. In her presentation, Feigal sets the context for the workshop and describes the CIRM research portfolio and lessons learned about product development.
 
Learn more about California's progress toward stem cell therapies

© 2013 California Institute for Regenerative Medicine